Search

Displaying results 8121 - 8130 of 10000 in total
  1. Drug

    7-Nitroindazole

    go.drugbank.com/drugs/DB02207
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Maltodextrin

    go.drugbank.com/drugs/DB12583
    Investigational

    Mixtures: Re-action E
  3. Drug

    Bambusa arundinacea stem

    go.drugbank.com/drugs/DB14588
    Investigational

    Mixtures: Re-action E
  4. Drug

    Isepamicin

    go.drugbank.com/drugs/DB13540
    Experimental

    Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic Use
  5. Drug

    Arecoline

    go.drugbank.com/drugs/DB04365
    Experimental

    It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands. … An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors.

  6. Drug

    Idrocilamide

    go.drugbank.com/drugs/DB13297
    Experimental

    Synonyms: N-(2-hydroxyethyl)cinnamamideCategories: Topical Products for Joint and Muscular Pain
  7. Drug

    Tibezonium iodide

    go.drugbank.com/drugs/DB13702
    Experimental

    Categories: Antiinfectives and Antiseptics for Local Oral Treatment
  8. Drug

    Vudalimab

    go.drugbank.com/drugs/DB18833
    Investigational

    Vudalimab is under investigation in clinical trial NCT05005728 (Xmab®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-resistant Prostate

    Synonyms: Pd-1 x ctla-4 dual checkpoint inhibitor xmab20717, Immunoglobulin half-ig g1-kappa/scfv-h-ch2-ch3, anti-(homo sapiens ctla4 (cytotoxic t-lymphocyte-associated protein 4, cd152)) and anti-(homo sapienspdcd1 (programmed cell death 1, pd-1, pd1, cd279)),
  9. Drug

    MW33

    go.drugbank.com/drugs/DB16358
    Experimental

    [L27411] This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection). … MW33 is a recombinant fully human antibody to SARS-CoV-2.

  10. Drug

    Pidacmeran

    go.drugbank.com/drugs/DB16401
    Investigational

    Pidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).